DoD Multiple Sclerosis, Exploration - Hypothesis Development Award | HT942524MSRPEHDA

FAQs: DoD Multiple Sclerosis Research Program (MSRP) Exploration - Hypothesis Development Award (EHDA)

What is the MSRP Exploration - Hypothesis Development Award (EHDA)?

The EHDA is a discretionary U.S. Department of the Army grant opportunity administered through USAMRAA under the DoD Multiple Sclerosis Research Program (MSRP). It is designed to fund early-stage multiple sclerosis (MS) research concepts that are bold, innovative, and exploratory, especially ideas that may be too early or uncertain for more traditional funding mechanisms.

What is the main goal of this award?

The main goal is to support the initial exploration of high-risk, high-gain concepts in MS research and to generate a strong foundation for follow-on studies and future lines of scientific investigation.

What kind of projects is the EHDA intended to support?

The EHDA is intended for hypothesis-driven projects that are innovative and potentially transformative. It is positioned for research that represents a real conceptual leap rather than incremental progress, with the expectation that the proposed work will help establish whether the underlying idea holds enough promise to justify further development.

Is a hypothesis required for the application?

Yes. A central requirement is a well-formulated and testable hypothesis supported by a clear scientific rationale and a solid study design that can realistically test the hypothesis.

Does the EHDA require preliminary or published data?

No. The program does not require preliminary or published data, which is intended to make space for hypothesis-generating or first-in-field experiments where existing evidence may be limited.

If preliminary data is not required, how important is rigor and study design?

Rigor remains a key expectation. Even without preliminary data, applicants are still expected to present a logically constructed research question, a methodologically sound approach, and a realistic plan capable of testing the hypothesis.

How does the program define "innovation" for this award?

Innovation is the defining feature of the EHDA. Competitive projects are expected to go beyond incremental extensions of existing work and instead introduce a novel paradigm, challenge current paradigms, reframe established problems from a new angle, or otherwise demonstrate creativity that could shift how MS is understood, studied, or managed.

What types of proposals may be considered a poor fit for the EHDA?

Proposals that mainly add another small step to ongoing research or closely track already published results are described as not aligning with the intent of the EHDA. The program is looking for concepts that represent a genuine leap rather than incremental progression.

Do applicants need to explicitly explain what is innovative about their project?

Yes. The Principal Investigator is expected to clearly and explicitly explain what makes the project innovative within the MS field, rather than assuming reviewers will infer novelty.

Is there any special requirement for the focus area "Correlates of Disease Activity and Progression in MS"?

Yes. If applying under the focus area "Correlates of Disease Activity and Progression in MS," applicants must demonstrate access to the relevant specimens and/or data for the cohort they plan to study.

How do applicants demonstrate access to required cohorts, specimens, or data?

The opportunity points to documentation such as letters confirming access. The intent is to substantiate feasibility by showing the team can obtain the needed samples and/or datasets.

Why does the program emphasize access to data and biospecimens even though it supports high-risk ideas?

While the EHDA welcomes scientific risk and early-stage uncertainty, it still expects applicants to remove avoidable feasibility risks. Confirming access to needed data and biospecimens helps ensure the project can actually be carried out as proposed.

What if my project uses animal models of MS?

If animal models are used, applicants are expected to choose models thoughtfully and justify clearly and specifically why the selected model is relevant to the particular aspect of human MS being investigated.

What kind of justification is expected for animal model selection?

The proposal should make a convincing case that the chosen model is appropriate for testing the specific hypothesis and relevant to the human MS biology or disease feature being studied, recognizing that different models capture different aspects of MS.

Is there a New Investigator option?

Yes. The EHDA includes a New Investigator option intended to encourage and support investigators who are early in establishing themselves in MS research and early in their faculty appointments.

How are New Investigator applications reviewed compared to Established Investigator applications?

The program separates Established Investigator and New Investigator applications for peer and programmatic review, which can help ensure early-career proposals are evaluated in an appropriate context.

Are New Investigators encouraged to collaborate?

Yes. New Investigators are encouraged to strengthen their submissions through collaboration with researchers who have MS-specific experience or other relevant expertise, particularly collaborators with demonstrated funding and publication track records.

What is the funding opportunity identifier and CFDA number?

The funding opportunity is listed as HT942524MSRPEHDA under CFDA 12.420.

What category and funding instrument does this opportunity use?

It is categorized under Science and Technology and other Research and Development, and it uses the grant funding instrument.

Who is eligible to apply?

Eligibility is listed as unrestricted, indicating a broad set of applicant organizations may apply, subject to the standard terms in the full announcement.

When is the application closing date?

The original application closing date is October 7, 2024.

How many awards does the program anticipate making?

The program anticipates making about eight awards.

What is the maximum award amount (award ceiling)?

The listing includes an award ceiling field, but a numeric value is not provided in the supplied information. Applicants would need to consult the full funding announcement for budget limits and any cost restrictions.

Where can applicants find details like budget limits, performance period, and cost restrictions?

The supplied information indicates that these details are not included in the provided listing excerpt. Applicants should consult the full funding announcement for budget limits, performance period details, and any cost restrictions.

What makes an application especially competitive for this award?

Based on the provided description, competitive applications typically combine genuine novelty with a credible, rigorous plan for testing a well-constructed hypothesis, clearly explain why the work is innovative, demonstrate access to required cohorts/specimens/data when applicable, and justify key feasibility choices (such as animal model relevance) in a scientifically grounded way.